36th EACTS Annual Meeting

OBJECTIVE

To assess the mid-term performance of CardioCel in the repair of congenital heart defects (CHD) using retrospective data from three Australian paediatric cardiac centres

STUDY PERIOD

October 2012 to December 2019

PRIMARY ENDPOINT

Need for CardioCel-related surgical or catheter reintervention

CONCLUSIONS

CardioCel provides acceptable results for the repair of some types of CHD at midterm follow up. Higher reintervention probability when used for augmentation of pulmonary arteries in neonates and aortic valve repair (any age).